Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anatomic Stage II Breast Cancer AJCC v8 × ribociclib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 18 Neoplasm Metastasis 3 Neoplasms 2 Melanoma 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Recurrence 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms by Site 1 Lung Neoplasms 1 Locoregional Recurrence 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 Endometrial Neoplasms 1 ER+ HER2- Advanced Breast Cancer 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Breast Diseases 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Taxes 2 Paclitaxel 2 trastuzumab biosimilar HLX02 1 pertuzumab 1 durvalumab 1 Trastuzumab 1 Surgical Procedures, Operative 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiation 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Mastectomy, Segmental 1 Mastectomy 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Genetic Testing 1 Fluorodeoxyglucose F18 1 Drug Therapy 1 Doxorubicin 1 Docetaxel 1 Disulfides 1 Cyclophosphamide 1 Albumin-Bound Paclitaxel 1 Ado-Trastuzumab Emtansine 1 2C4 antibody 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡